tiprankstipranks
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market

PharmAla Biotech Holdings, Inc. (MDMA) Financial Statements

Compare
57 Followers

PharmAla Biotech Holdings, Inc. Financial Overview

PharmAla Biotech Holdings, Inc.'s market cap is currently ―. The company's EPS TTM is C$-0.015; its P/E ratio is ―; PharmAla Biotech Holdings, Inc. is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21
Income Statement
Total RevenueC$ 1.04MC$ 532.00KC$ 78.07KC$ 0.00
Gross ProfitC$ 887.44KC$ 454.10KC$ 75.78KC$ -303.00
Operating IncomeC$ 0.00C$ -762.95KC$ -985.58KC$ -2.51M
EBITDAC$ -573.36KC$ -710.18KC$ -973.45KC$ -2.51M
Net IncomeC$ -823.60KC$ -779.81KC$ -985.58KC$ -2.51M
Balance Sheet
Cash & Short-Term InvestmentsC$ 419.38KC$ 195.04KC$ 852.14KC$ 2.47M
Total AssetsC$ 2.90MC$ 2.41MC$ 2.33MC$ 2.79M
Total DebtC$ 0.00C$ 253.54KC$ 0.00C$ 0.00
Net DebtC$ -419.38KC$ 58.49KC$ -852.14KC$ -2.47M
Total LiabilitiesC$ 916.88KC$ 1.03MC$ 423.78KC$ 138.48K
Stockholders' EquityC$ 1.98MC$ 1.38MC$ 1.91MC$ 2.66M
Cash Flow
Free Cash FlowC$ -547.78KC$ -846.39KC$ -1.62MC$ -435.76K
Operating Cash FlowC$ -321.36KC$ -339.66KC$ -625.37KC$ -173.57K
Investing Cash FlowC$ -226.42KC$ -506.74KC$ -994.87KC$ 629.22K
Financing Cash FlowC$ 772.12KC$ 189.29KC$ 0.00C$ 2.02M
Currency in CAD

PharmAla Biotech Holdings, Inc. Earnings and Revenue History

PharmAla Biotech Holdings, Inc. Debt to Assets

PharmAla Biotech Holdings, Inc. Cash Flow

PharmAla Biotech Holdings, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis